First infection with VanD-Type glycopeptide-resistant Enterococcus faecium in Europe

被引:7
作者
Lavigne, JP
Marchandin, H
Bouziges, N
Sotto, A
机构
[1] Univ Nimes, Fac Med, Lab Antibiol, F-30900 Nimes, France
[2] Grp Hosp Univ Caremeau, CHU Himes, Bacteriol Lab, F-30029 Nimes, France
[3] CHU Arnaud de Villeneuve, Bacteriol Lab, F-34295 Montpellier, France
[4] Grp Hosp Univ Caremeau, CHU Nimes, Serv Med Interne B, F-30029 Nimes, France
关键词
D O I
10.1128/JCM.43.7.3512-3515.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We report the first strain of glycopeptide-resistant Enterococcus faecium from Europe that contains a vanD allele isolated from blood cultures of an immunocompromised patient hospitalized in a French university hospital. Based on phenotypic results, PCR sequencing, pulsed-field gel electrophoresis, and Southern blotting, the isolate was assigned to E. faecium with a chromosomally located VanD allele most closely related to the VanD1 allele.
引用
收藏
页码:3512 / 3515
页数:4
相关论文
共 20 条
[1]   CHARACTERIZATION OF TN1546, A TN3-RELATED TRANSPOSON CONFERRING GLYCOPEPTIDE RESISTANCE BY SYNTHESIS OF DEPSIPEPTIDE PEPTIDOGLYCAN PRECURSORS IN ENTEROCOCCUS-FAECIUM BM4147 [J].
ARTHUR, M ;
MOLINAS, C ;
DEPARDIEU, F ;
COURVALIN, P .
JOURNAL OF BACTERIOLOGY, 1993, 175 (01) :117-127
[2]   Chromosome-encoded class D β-lactamase OXA-23 in Proteus mirabilis [J].
Bonnet, R ;
Marchandin, H ;
Chanal, C ;
Sirot, D ;
Labia, R ;
De Champs, C ;
Jumas-Bilak, E ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :2004-2006
[3]   Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant:: characterization of the VanD5 operon [J].
Boyd, DA ;
Kibsey, P ;
Roscoe, D ;
Mulvey, MR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (03) :680-683
[4]  
Boyd DA, 2000, J CLIN MICROBIOL, V38, P2392
[5]   Characterization of the vanD glycopeptide resistance gene cluster from Entercoccus faecium BM4339 [J].
Casadewall, B ;
Courvalin, P .
JOURNAL OF BACTERIOLOGY, 1999, 181 (12) :3644-3648
[6]   Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil [J].
Dalla Costa, LM ;
Reynolds, PE ;
Souza, HAPHM ;
Souza, DC ;
Palepou, MFI ;
Woodford, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3444-3446
[7]   VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis [J].
Depardieu, F ;
Kolbert, M ;
Pruul, H ;
Bell, J ;
Courvalin, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3892-3904
[8]   DETECTION OF GLYCOPEPTIDE RESISTANCE GENOTYPES AND IDENTIFICATION TO THE SPECIES LEVEL OF CLINICALLY RELEVANT ENTEROCOCCI BY PCR [J].
DUTKAMALEN, S ;
EVERS, S ;
COURVALIN, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :24-27
[9]   Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR(B) two-component regulatory system in Enterococcus faecalis V583 [J].
Evers, S ;
Courvalin, P .
JOURNAL OF BACTERIOLOGY, 1996, 178 (05) :1302-1309
[10]   VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405 [J].
Fines, M ;
Perichon, B ;
Reynolds, P ;
Sahm, DF ;
Courvalin, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2161-2164